<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36208897</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>165</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>International review of neurobiology</Title><ISOAbbreviation>Int Rev Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Spotlight on non-motor symptoms and Covid-19.</ArticleTitle><Pagination><StartPage>103</StartPage><EndPage>133</EndPage><MedlinePgn>103-133</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/bs.irn.2022.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0074-7742(22)00030-7</ELocationID><Abstract><AbstractText>The Coronavirus Disease 2019 (Covid-19) pandemic has profoundly affected the quality of life (QoL) and health of the general population globally over the past 2 years, with a clear impact on people with Parkinson's Disease (PwP, PD). Non-motor symptoms have been widely acknowledged to hold a vital part in the clinical spectrum of PD, and, although often underrecognized, they significantly contribute to patients' and their caregivers' QoL. Up to now, there have been numerous reports of newly emerging or acutely deteriorating non-motor symptoms in PwP who had been infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), while some of these symptoms, like fatigue, pain, depression, anxiety and cognitive impairment, have also been identified as part of the long-COVID syndrome due to their persistent nature. The subjacent mechanisms, mediating the appearance or progression of non-motor symptoms in the context of Covid-19, although probably multifactorial in origin, remain largely unknown. Such mechanisms might be, at least partly, related solely to the viral infection per se or the lifestyle changes imposed during the pandemic, as many of the non-motor symptoms seem to be prevalent even among Covid-19 patients without PD. Here, we summarize the available evidence and implications of Covid-19 in non-motor PD symptoms in the acute and chronic, if applicable, phase of the infection, with a special reference on studies of PwP.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rota</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology &amp;amp; Neuroscience, King's College London, London, United Kingdom; Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boura</LastName><ForeName>Iro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology &amp;amp; Neuroscience, King's College London, London, United Kingdom; Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, United Kingdom; Medical School, University of Crete, Heraklion, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Yi-Min</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology &amp;amp; Neuroscience, King's College London, London, United Kingdom; Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, United Kingdom; Department of Psychiatry, Ng Teng Fong General Hospital, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazcano-Ocampo</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, United Kingdom; Department of Neurology, Movement Disorders Unit, Hospital Sotero del Rio, Santiago, Chile; Department of Neurology, Cl&#xed;nica INDISA, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Violante</LastName><ForeName>Mayela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Neurologia y Neurocirugia, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonini</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Parkinson and Movement Disorders Unit, Department of Neuroscience, Centre for Rare Neurological Diseases (ERN-RND), University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhuri</LastName><ForeName>Kallol Ray</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology &amp;amp; Neuroscience, King's College London, London, United Kingdom; Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, United Kingdom. Electronic address: ray.chaudhuri@kcl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int Rev Neurobiol</MedlineTA><NlmUniqueID>0374740</NlmUniqueID><ISSNLinking>0074-7742</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Gastrointestinal</Keyword><Keyword MajorTopicYN="N">Non-motor symptoms</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Sleep</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>8</Day><Hour>21</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36208897</ArticleId><ArticleId IdType="pmc">PMC9270874</ArticleId><ArticleId IdType="doi">10.1016/bs.irn.2022.04.001</ArticleId><ArticleId IdType="pii">S0074-7742(22)00030-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aarsland D., Batzu L., Halliday G.M., Geurtsen G.J., Ballard C., Ray Chaudhuri K., et al. Parkinson disease-associated cognitive impairment. Nature Reviews. Disease Primers. 2021;7(1):47. doi: 10.1038/s41572-021-00280-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00280-3</ArticleId><ArticleId IdType="pubmed">34210995</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate S.M., Checkol Y.A., Mantefardo B. Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis. Annals of Medicine and Surgery. 2021;64 doi: 10.1016/j.amsu.2021.102204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102204</ArticleId><ArticleId IdType="pmc">PMC7931690</ArticleId><ArticleId IdType="pubmed">33692899</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleem A., Kothadia J.P. StatPearls. StatPearls Publishing; Treasure Island (FL): 2021. Remdesivir. (Copyright &#xa9; 2021, StatPearls Publishing LLC)</Citation></Reference><Reference><Citation>Alimoradi Z., Brostr&#xf6;m A., Tsang H.W.H., Griffiths M.D., Haghayegh S., Ohayon M.M., et al. Sleep problems during COVID-19 pandemic and its' association to psychological distress: A systematic review and meta-analysis. EClinicalMedicine. 2021;36 doi: 10.1016/j.eclinm.2021.100916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100916</ArticleId><ArticleId IdType="pmc">PMC8192091</ArticleId><ArticleId IdType="pubmed">34131640</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews P.L.R., Cai W., Rudd J.A., Sanger G.J. COVID-19, nausea, and vomiting. Journal of Gastroenterology and Hepatology. 2021;36(3):646&#x2013;656. doi: 10.1111/jgh.15261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15261</ArticleId><ArticleId IdType="pmc">PMC7537541</ArticleId><ArticleId IdType="pubmed">32955126</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini A., Leta V., Teo J., Chaudhuri K.R. Outcome of Parkinson's disease patients affected by COVID-19. Movement Disorders: Official Journal of the Movement Disorder Society. 2020;35(6):905&#x2013;908. doi: 10.1002/mds.28104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28104</ArticleId><ArticleId IdType="pmc">PMC7267273</ArticleId><ArticleId IdType="pubmed">32347572</ArticleId></ArticleIdList></Reference><Reference><Citation>Artusi C.A., Romagnolo A., Imbalzano G., Marchet A., Zibetti M., Rizzone M.G., et al. COVID-19 in Parkinson's disease: Report on prevalence and outcome. Parkinsonism &amp; Related Disorders. 2020;80:7&#x2013;9. doi: 10.1016/j.parkreldis.2020.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.09.008</ArticleId><ArticleId IdType="pmc">PMC7474816</ArticleId><ArticleId IdType="pubmed">32920322</ArticleId></ArticleIdList></Reference><Reference><Citation>Arumugham V.B., Gujarathi R., Cascella M. StatPearls Publishing; Treasure Island (FL): 2021. Third generation cephalosporins. In StatPearls. (Copyright &#xa9; 2021, StatPearls Publishing LLC)</Citation><ArticleIdList><ArticleId IdType="pubmed">31751071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhidayasiri R., Virameteekul S., Kim J.M., Pal P.K., Chung S.J. COVID-19: An early review of its global impact and considerations for Parkinson's disease patient care. The Journal of Movement Disorders. 2020;13(2):105&#x2013;114. doi: 10.14802/jmd.20042.</Citation><ArticleIdList><ArticleId IdType="doi">10.14802/jmd.20042</ArticleId><ArticleId IdType="pmc">PMC7280938</ArticleId><ArticleId IdType="pubmed">32344993</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: A case series of 20 patients. Immunologic Research. 2021;69(2):205&#x2013;211. doi: 10.1007/s12026-021-09185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Broen M.P., Narayen N.E., Kuijf M.L., Dissanayaka N.N., Leentjens A.F. Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis. Movement Disorders. 2016;31(8):1125&#x2013;1133. doi: 10.1002/mds.26643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26643</ArticleId><ArticleId IdType="pubmed">27125963</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown E.G., Chahine L.M., Goldman S.M., Korell M., Mann E., Kinel D.R., et al. The effect of the COVID-19 pandemic on people with Parkinson's disease. Journal of Parkinson's Disease. 2020;10(4):1365&#x2013;1377. doi: 10.3233/jpd-202249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jpd-202249</ArticleId><ArticleId IdType="pmc">PMC7683050</ArticleId><ArticleId IdType="pubmed">32925107</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundin P., Nath A., Beckham J.D. Is COVID-19 a perfect storm for Parkinson's disease? Trends in Neurosciences. 2020;43(12):931&#x2013;933. doi: 10.1016/j.tins.2020.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.10.009</ArticleId><ArticleId IdType="pmc">PMC7577682</ArticleId><ArticleId IdType="pubmed">33158605</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (New York, N.Y.) 2020;370(6518):856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. StatPearls. StatPearls Publishing; Treasure Island (FL): 2021. Features, evaluation, and treatment of coronavirus (COVID-19) (Copyright &#xa9; 2021, StatPearls Publishing LLC)</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: Diagnosis and management. Lancet Neurology. 2006;5(3):235&#x2013;245. doi: 10.1016/s1474-4422(06)70373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(06)70373-8</ArticleId><ArticleId IdType="pubmed">16488379</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri K.R., Yates L., Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: A comprehensive assessment is essential. Current Neurology and Neuroscience Reports. 2005;5(4):275&#x2013;283. doi: 10.1007/s11910-005-0072-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-005-0072-6</ArticleId><ArticleId IdType="pubmed">15987611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-Y., Yu S., Hu Y.-H., Li C.-Y., Artaud F., Carcaillon-Bentata L., et al. Risk of suicide among patients with Parkinson disease. JAMA Psychiatry. 2021;78(3):293&#x2013;301. doi: 10.1001/jamapsychiatry.2020.4001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.4001</ArticleId><ArticleId IdType="pmc">PMC7745139</ArticleId><ArticleId IdType="pubmed">33326004</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinnappa-Quinn L., Makkar S.R., Bennett M., Lam B.C.P., Lo J.W., Kochan N.A., et al. Is hospitalization a risk factor for cognitive decline in older age adults? International Psychogeriatrics. 2020;1-18 doi: 10.1017/s1041610220001763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1041610220001763</ArticleId><ArticleId IdType="pubmed">32985398</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilia R., Bonvegna S., Straccia G., Andreasi N.G., Elia A.E., Romito L.M., et al. Effects of COVID-19 on Parkinson's disease clinical features: A community-based case-control study. Movement Disorders. 2020;35(8):1287&#x2013;1292. doi: 10.1002/mds.28170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28170</ArticleId><ArticleId IdType="pmc">PMC7280741</ArticleId><ArticleId IdType="pubmed">32449528</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti E.J., Johnson A.R., Gasson N., Bucks R.S., Thomas M.G., Loftus A.M. Factor structure of the ways of coping questionnaire in Parkinson's disease. Parkinsons Disease. 2018;2018:7128069. doi: 10.1155/2018/7128069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/7128069</ArticleId><ArticleId IdType="pmc">PMC6304892</ArticleId><ArticleId IdType="pubmed">30631419</ArticleId></ArticleIdList></Reference><Reference><Citation>Crocker J., Liu K., Smith M., Nakamoto M., Mitchell C., Zhu E., et al.  Early impact of the COVID-19 pandemic on outpatient neurologic Care in Hawai'i. Hawai'i Journal of Health &amp; Social Welfare. 2022;81(1):6&#x2013;12. (Retrieved from  https://pubmed.ncbi.nlm.nih.gov/35028589.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742305/)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742305</ArticleId><ArticleId IdType="pubmed">35028589</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano R.F., Guedes B.F., de Rocca C.C., de P&#xe1;dua Serafim A., Castro L.H.M., Munhoz C.D., et al. Cognitive decline following acute viral infections: Literature review and projections for post-COVID-19. European Archives of Psychiatry and Clinical Neuroscience. 2021;1-16 doi: 10.1007/s00406-021-01286-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-021-01286-4</ArticleId><ArticleId IdType="pmc">PMC8231753</ArticleId><ArticleId IdType="pubmed">34173049</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico F., Baumgart D.C., Danese S., Peyrin-Biroulet L. Diarrhea during COVID-19 infection: Pathogenesis, epidemiology, prevention, and management. Clinical Gastroenterology and Hepatology. 2020;18(8):1663&#x2013;1672. doi: 10.1016/j.cgh.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7141637</ArticleId><ArticleId IdType="pubmed">32278065</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ascanio L., Pandolfini M., Cingolani C., Latini G., Gradoni P., Capalbo M., et al. Olfactory dysfunction in COVID-19 patients: Prevalence and prognosis for recovering sense of smell. Otolaryngology and Head and Neck Surgery. 2021;164(1):82&#x2013;86. doi: 10.1177/0194599820943530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820943530</ArticleId><ArticleId IdType="pubmed">32662745</ArticleId></ArticleIdList></Reference><Reference><Citation>de Freitas R.F., Torres S.C., Mart&#xed;n-S&#xe1;nchez F.J., Carb&#xf3; A.V., Lauria G., Nunes J.P.L. Syncope and COVID-19 disease - a systematic review. Autonomic Neuroscience. 2021;235 doi: 10.1016/j.autneu.2021.102872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102872</ArticleId><ArticleId IdType="pmc">PMC8393505</ArticleId><ArticleId IdType="pubmed">34500351</ArticleId></ArticleIdList></Reference><Reference><Citation>De Micco R., Siciliano M., Sant'Elia V., Giordano A., Russo A., Tedeschi G., et al. Correlates of psychological distress in patients with Parkinson's disease during the COVID-19 outbreak. Movement Disorders Clinical Practice. 2021;8(1):60&#x2013;68. doi: 10.1002/mdc3.13108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13108</ArticleId><ArticleId IdType="pmc">PMC7780948</ArticleId><ArticleId IdType="pubmed">33426160</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rus Jacquet A., Bogard S., Normandeau C.P., Degroot C., Postuma R.B., Dupr&#xe9; N., et al. Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience. Parkinsonism &amp; Related Disorders. 2021;91:66&#x2013;76. doi: 10.1016/j.parkreldis.2021.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2021.08.018</ArticleId><ArticleId IdType="pmc">PMC8407944</ArticleId><ArticleId IdType="pubmed">34536727</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete E., Francesconi A., Palermo G., Mazzucchi S., Frosini D., Morganti R., et al. Prevalence and impact of COVID-19 in Parkinson's disease: Evidence from a multi-center survey in Tuscany region. Journal of Neurology. 2021;268(4):1179&#x2013;1187. doi: 10.1007/s00415-020-10002-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10002-6</ArticleId><ArticleId IdType="pmc">PMC7471534</ArticleId><ArticleId IdType="pubmed">32880722</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio R., Marcus N.J., Inestrosa N.C. Potential role of autonomic dysfunction in Covid-19 morbidity and mortality. Frontiers in Physiology. 2020;11 doi: 10.3389/fphys.2020.561749. 561749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.561749</ArticleId><ArticleId IdType="pmc">PMC7597395</ArticleId><ArticleId IdType="pubmed">33178034</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh V., Motwani R., Kumar A., Kumari C., Raza K. Histopathological observations in COVID-19: A systematic review. Journal of Clinical Pathology. 2021;74(2):76&#x2013;83. doi: 10.1136/jclinpath-2020-206995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-206995</ArticleId><ArticleId IdType="pubmed">32817204</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az H.S., Toledo C., Andrade D.C., Marcus N.J., Del Rio R. Neuroinflammation in heart failure: New insights for an old disease. The Journal of Physiology. 2020;598(1):33&#x2013;59. doi: 10.1113/jp278864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jp278864</ArticleId><ArticleId IdType="pubmed">31671478</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. 2022 doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Douma E.H., de Kloet E.R. Stress-induced plasticity and functioning of ventral tegmental dopamine neurons. Neuroscience and Biobehavioral Reviews. 2020;108:48&#x2013;77. doi: 10.1016/j.neubiorev.2019.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2019.10.015</ArticleId><ArticleId IdType="pubmed">31666179</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubovsky A.N., Arvikar S., Stern T.A., Axelrod L. The neuropsychiatric complications of glucocorticoid use: Steroid psychosis revisited. Psychosomatics. 2012;53(2):103&#x2013;115. doi: 10.1016/j.psym.2011.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psym.2011.12.007</ArticleId><ArticleId IdType="pubmed">22424158</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehlenbach W.J., Hough C.L., Crane P.K., Haneuse S.J., Carson S.S., Curtis J.R., et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA. 2010;303(8):763&#x2013;770. doi: 10.1001/jama.2010.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.167</ArticleId><ArticleId IdType="pmc">PMC2943865</ArticleId><ArticleId IdType="pubmed">20179286</ArticleId></ArticleIdList></Reference><Reference><Citation>El Otmani H., El Bidaoui Z., Amzil R., Bellakhdar S., El Moutawakil B., Abdoh Rafai M. No impact of confinement during COVID-19 pandemic on anxiety and depression in parkinsonian patients. Revue Neurologique (Paris) 2021;177(3):272&#x2013;274. doi: 10.1016/j.neurol.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7877213</ArticleId><ArticleId IdType="pubmed">33610345</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sayed S., Shokry D., Gomaa S.M. Post-COVID-19 fatigue and anhedonia: A cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacology Reports. 2021;41(1):50&#x2013;55. doi: 10.1002/npr2.12154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/npr2.12154</ArticleId><ArticleId IdType="pmc">PMC8182964</ArticleId><ArticleId IdType="pubmed">33332756</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbeddini A., To A., Tayefehchamani Y., Wen C. Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic. Journal of Clinical Movement Disorders. 2020;7:7. doi: 10.1186/s40734-020-00089-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40734-020-00089-4</ArticleId><ArticleId IdType="pmc">PMC7414276</ArticleId><ArticleId IdType="pubmed">32782815</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfil M., Kamel S., Kandil M., Koo B.B., Schaefer S.M. Implications of the gut microbiome in Parkinson's disease. Movement Disorders. 2020;35(6):921&#x2013;933. doi: 10.1002/mds.28004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28004</ArticleId><ArticleId IdType="pubmed">32092186</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliasen A., Dalhoff K.P., Horwitz H. Neurological diseases and risk of suicide attempt: A case-control study. Journal of Neurology. 2018;265(6):1303&#x2013;1309. doi: 10.1007/s00415-018-8837-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8837-4</ArticleId><ArticleId IdType="pubmed">29564603</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Qushayri A.E., Ghozy S., Reda A., Kamel A.M.A., Abbas A.S., Dmytriw A.A. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis. Reviews in Medical Virology. 2021;e2278 doi: 10.1002/rmv.2278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2278</ArticleId><ArticleId IdType="pmc">PMC8420424</ArticleId><ArticleId IdType="pubmed">34260773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely E.W., Shintani A., Truman B., Speroff T., Gordon S.M., Harrell F.E., Jr., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753&#x2013;1762. doi: 10.1001/jama.291.14.1753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.14.1753</ArticleId><ArticleId IdType="pubmed">15082703</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlangsen A., Stenager E., Conwell Y., Andersen P.K., Hawton K., Benros M.E., et al. Association between neurological disorders and death by suicide in Denmark. JAMA. 2020;323(5):444&#x2013;454. doi: 10.1001/jama.2019.21834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.21834</ArticleId><ArticleId IdType="pmc">PMC7042859</ArticleId><ArticleId IdType="pubmed">32016308</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri M., Leung C., Baille G., B&#xe9;reau M., Brefel Courbon C., Castelnovo G., et al. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study. Parkinsonism &amp; Related Disorders. 2021;89:128&#x2013;133. doi: 10.1016/j.parkreldis.2021.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2021.07.013</ArticleId><ArticleId IdType="pmc">PMC9272278</ArticleId><ArticleId IdType="pubmed">34293534</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A., Visanji N.P., Liu L.W., Lang A.E., Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurology. 2015;14(6):625&#x2013;639. doi: 10.1016/s1474-4422(15)00007-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(15)00007-1</ArticleId><ArticleId IdType="pubmed">25987282</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger J.C., Miller A.H. Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise. Frontiers in Neuroendocrinology. 2012;33(3):315&#x2013;327. doi: 10.1016/j.yfrne.2012.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2012.09.003</ArticleId><ArticleId IdType="pmc">PMC3484236</ArticleId><ArticleId IdType="pubmed">23000204</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. 2022 doi: 10.1101/2022.01.07.475453. 2022.2001.2007.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjerde K.V., M&#xfc;ller B., Skeie G.O., Assmus J., Alves G., Tysnes O.B. Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease. Acta Neurologica Scandinavica. 2018;138(6):508&#x2013;514. doi: 10.1111/ane.13003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13003</ArticleId><ArticleId IdType="pubmed">30058142</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy L.D., Rossignoli M.T., Delfino-Pereira P., Garcia-Cairasco N., de Lima Umeoka E.H. A comprehensive overview on stress neurobiology: Basic concepts and clinical implications. Frontiers in Behavioral Neuroscience. 2018;12:127. doi: 10.3389/fnbeh.2018.00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2018.00127</ArticleId><ArticleId IdType="pmc">PMC6043787</ArticleId><ArticleId IdType="pubmed">30034327</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracner T., Agarwal M., Murali K.P., Stone P.W., Larson E.L., Furuya E.Y., et al. Association of Infection-Related Hospitalization with Cognitive Impairment among Nursing Home Residents. JAMA Network Open. 2021;4(4) doi: 10.1001/jamanetworkopen.2021.7528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.7528</ArticleId><ArticleId IdType="pmc">PMC8065379</ArticleId><ArticleId IdType="pubmed">33890988</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano M.R., Lo Moro G., Voglino G., Bert F., Siliquini R. Effects of Covid-19 lockdown on mental health and sleep disturbances in Italy. International Journal of Environmental Research and Public Health. 2020;17(13) doi: 10.3390/ijerph17134779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17134779</ArticleId><ArticleId IdType="pmc">PMC7369943</ArticleId><ArticleId IdType="pubmed">32630821</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero J.I., Barrag&#xe1;n L.A., Mart&#xed;nez J.D., Montoya J.P., Pe&#xf1;a A., Sobrino F.E., et al. Central and peripheral nervous system involvement by COVID-19: A systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infectious Diseases. 2021;21(1):515. doi: 10.1186/s12879-021-06185-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06185-6</ArticleId><ArticleId IdType="pmc">PMC8170436</ArticleId><ArticleId IdType="pubmed">34078305</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D., Han B., Lu Y., Lv C., Fang X., Zhang Z., et al. Influence of the COVID-19 pandemic on quality of life of patients with Parkinson's disease. Parkinsons Disease. 2020;2020:1216568. doi: 10.1155/2020/1216568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/1216568</ArticleId><ArticleId IdType="pmc">PMC7537675</ArticleId><ArticleId IdType="pubmed">33062247</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas A.N., Passos-Monteiro E., Delabary M.D.S., Moratelli J., Schuch F.B., Correa C.L., et al. Association between mental health and physical activity levels in people with Parkinson's disease during the COVID-19 pandemic: An observational cross-sectional survey in Brazil. Sport Science for Health. 2022;1-7 doi: 10.1007/s11332-021-00868-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11332-021-00868-y</ArticleId><ArticleId IdType="pmc">PMC8758246</ArticleId><ArticleId IdType="pubmed">35043063</ArticleId></ArticleIdList></Reference><Reference><Citation>Haehner A., Hummel T., Reichmann H. Olfactory loss in Parkinson's disease. Parkinson's Disease. 2011;2011 doi: 10.4061/2011/450939. 450939.</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/450939</ArticleId><ArticleId IdType="pmc">PMC3109349</ArticleId><ArticleId IdType="pubmed">21687752</ArticleId></ArticleIdList></Reference><Reference><Citation>Hainque E., Grabli D. Rapid worsening in Parkinson's disease may hide COVID-19 infection. Parkinsonism &amp; Related Disorders. 2020;75:126&#x2013;127. doi: 10.1016/j.parkreldis.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7205634</ArticleId><ArticleId IdType="pubmed">32414669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto T.I., Rizki N.A., Kurniawan A. Anosmia/hyposmia is a good predictor of coronavirus disease 2019 (COVID-19) infection: A meta-analysis. International Archives of Otorhinolaryngology. 2021;25(1):e170&#x2013;e174. doi: 10.1055/s-0040-1719120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1719120</ArticleId><ArticleId IdType="pmc">PMC7857970</ArticleId><ArticleId IdType="pubmed">33552295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassani M., Fathi Jouzdani A., Motarjem S., Ranjbar A., Khansari N. How COVID-19 can cause autonomic dysfunctions and postural orthostatic syndrome? A review of mechanisms and evidence. Neurology and Clinical Neuroscience. 2021;9(6):434&#x2013;442. doi: 10.1111/ncn3.12548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12548</ArticleId><ArticleId IdType="pmc">PMC8661735</ArticleId><ArticleId IdType="pubmed">34909198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes C.H., Del Tredici K., Braak H. Parkinson's disease: A dual-hit hypothesis. Neuropathology and Applied Neurobiology. 2007;33(6):599&#x2013;614. doi: 10.1111/j.1365-2990.2007.00874.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2007.00874.x</ArticleId><ArticleId IdType="pmc">PMC7194308</ArticleId><ArticleId IdType="pubmed">17961138</ArticleId></ArticleIdList></Reference><Reference><Citation>He R., Zhao Y., He Y., Zhou Y., Yang J., Zhou X., et al. Olfactory dysfunction predicts disease progression in Parkinson's disease: A longitudinal study. Frontiers in Neuroscience. 2020;14 doi: 10.3389/fnins.2020.569777. 569777.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.569777</ArticleId><ArticleId IdType="pmc">PMC7768001</ArticleId><ArticleId IdType="pubmed">33381006</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmich R.C., Bloem B.R. The impact of the COVID-19 pandemic on Parkinson's disease: Hidden sorrows and emerging opportunities. Journal of Parkinson's Disease. 2020;10(2):351&#x2013;354. doi: 10.3233/JPD-202038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202038</ArticleId><ArticleId IdType="pmc">PMC7242824</ArticleId><ArticleId IdType="pubmed">32250324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280. doi: 10.1016/j.cell.2020.02.052. e278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xd8;rmann Thomsen T., Wallerstedt S.M., Winge K., Bergquist F. Life with Parkinson's disease during the COVID-19 pandemic: The pressure is "OFF". Journal of Parkinson's Disease. 2021;11(2):491&#x2013;495. doi: 10.3233/jpd-202342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jpd-202342</ArticleId><ArticleId IdType="pubmed">33459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahrami H., BaHammam A.S., Bragazzi N.L., Saif Z., Faris M., Vitiello M.V. Sleep problems during the COVID-19 pandemic by population: A systematic review and meta-analysis. Journal of Clinical Sleep Medicine. 2021;17(2):299&#x2013;313. doi: 10.5664/jcsm.8930.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.8930</ArticleId><ArticleId IdType="pmc">PMC7853219</ArticleId><ArticleId IdType="pubmed">33108269</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F.M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2021;46(13):2235&#x2013;2240. doi: 10.1038/s41386-021-00978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalimisetty S., Askar W., Fay B., Khan A. Models for predicting incident delirium in hospitalized older adults: A systematic review. Journal of Patient-Centered Research and Reviews. 2017;4(2):69&#x2013;77. doi: 10.17294/2330-0698.1414.</Citation><ArticleIdList><ArticleId IdType="doi">10.17294/2330-0698.1414</ArticleId><ArticleId IdType="pmc">PMC6664369</ArticleId><ArticleId IdType="pubmed">31413973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kano O., Ikeda K., Cridebring D., Takazawa T., Yoshii Y., Iwasaki Y. Neurobiology of depression and anxiety in Parkinson's disease. Parkinsons Disease. 2011;2011 doi: 10.4061/2011/143547.</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/143547</ArticleId><ArticleId IdType="pmc">PMC3109308</ArticleId><ArticleId IdType="pubmed">21687804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kariyawasam J.C., Jayarajah U., Riza R., Abeysuriya V., Seneviratne S.L. Gastrointestinal manifestations in COVID-19. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2021;115(12):1362&#x2013;1388. doi: 10.1093/trstmh/trab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trab042</ArticleId><ArticleId IdType="pmc">PMC7989191</ArticleId><ArticleId IdType="pubmed">33728439</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsen K.H., Larsen J.P., Tandberg E., Maeland J.G. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 1999;66(4):431&#x2013;435. doi: 10.1136/jnnp.66.4.431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.66.4.431</ArticleId><ArticleId IdType="pmc">PMC1736304</ArticleId><ArticleId IdType="pubmed">10201412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly M.J., Lawton M.A., Baig F., Ruffmann C., Barber T.R., Lo C., et al. Predictors of motor complications in early Parkinson's disease: A prospective cohort study. Movement Disorders. 2019;34(8):1174&#x2013;1183. doi: 10.1002/mds.27783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27783</ArticleId><ArticleId IdType="pmc">PMC6771533</ArticleId><ArticleId IdType="pubmed">31283854</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.S. Do an altered gut microbiota and an associated leaky gut affect COVID-19 severity? MBio. 2021;12(1) doi: 10.1128/mBio.03022-20. e03022-03020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03022-20</ArticleId><ArticleId IdType="pmc">PMC7845625</ArticleId><ArticleId IdType="pubmed">33436436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitani-Morii F., Kasai T., Horiguchi G., Teramukai S., Ohmichi T., Shinomoto M., et al. Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan. PLoS One. 2021;16(1) doi: 10.1371/journal.pone.0245864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245864</ArticleId><ArticleId IdType="pmc">PMC7822544</ArticleId><ArticleId IdType="pubmed">33481879</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingelhoefer L., Reichmann H. Pathogenesis of Parkinson disease&#x2014;The gut-brain axis and environmental factors. Nature Reviews. Neurology. 2015;11(11):625&#x2013;636. doi: 10.1038/nrneurol.2015.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.197</ArticleId><ArticleId IdType="pubmed">26503923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocevska D., Blanken T.F., Van Someren E.J.W., R&#xf6;sler L. Sleep quality during the COVID-19 pandemic: Not one size fits all. Sleep Medicine. 2020;76:86&#x2013;88. doi: 10.1016/j.sleep.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2020.09.029</ArticleId><ArticleId IdType="pmc">PMC7543757</ArticleId><ArticleId IdType="pubmed">33126035</ArticleId></ArticleIdList></Reference><Reference><Citation>Krey L., Huber M.K., H&#xf6;glinger G.U., Wegner F. Can SARS-CoV-2 infection Lead to neurodegeneration and Parkinson's disease? Brain Sciences. 2021;11(12) doi: 10.3390/brainsci11121654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11121654</ArticleId><ArticleId IdType="pmc">PMC8699589</ArticleId><ArticleId IdType="pubmed">34942956</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzyszton K., Mielanczuk-Lubecka B., Stolarski J., Poznanska A., Kepczynska K., Zdrowowicz A., et al. Secondary impact of COVID-19 pandemic on people with Parkinson's disease-results of a polish online survey. Brain Sciences. 2021;12(1) doi: 10.3390/brainsci12010026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12010026</ArticleId><ArticleId IdType="pmc">PMC8774235</ArticleId><ArticleId IdType="pubmed">35053770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N., Gupta R., Kumar H., Mehta S., Rajan R., Kumar D., et al. Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson's disease. Sleep Medicine. 2021;77:15&#x2013;22. doi: 10.1016/j.sleep.2020.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2020.11.021</ArticleId><ArticleId IdType="pmc">PMC7682933</ArticleId><ArticleId IdType="pubmed">33302094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazcano-Ocampo C., Wan Y.M., van Wamelen D.J., Batzu L., Boura I., Titova N., et al. Identifying and responding to fatigue and apathy in Parkinson's disease: A review of current practice. Expert Review of Neurotherapeutics. 2020;20(5):477&#x2013;495. doi: 10.1080/14737175.2020.1752669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1752669</ArticleId><ArticleId IdType="pubmed">32290717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Place S., Van Laethem Y., Cabaraux P., Mat Q., et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. Journal of Internal Medicine. 2020;288(3):335&#x2013;344. doi: 10.1111/joim.13089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13089</ArticleId><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V., Rodr&#xed;guez-Violante M., Abundes A., Rukavina K., Teo J.T., Falup-Pecurariu C., et al. Parkinson's disease and post-COVID-19 syndrome: The Parkinson's long-COVID Spectrum. Movement Disorders. 2021;36(6):1287&#x2013;1289. doi: 10.1002/mds.28622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28622</ArticleId><ArticleId IdType="pmc">PMC8250675</ArticleId><ArticleId IdType="pubmed">33890344</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Abbas M.M., Acharyya S., Ng H.L., Tay K.Y., Au W.L., et al. Suicide in Parkinson's disease. Movement Disorders Clinical Practice. 2018;5(2):177&#x2013;182. doi: 10.1002/mdc3.12599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.12599</ArticleId><ArticleId IdType="pmc">PMC6174449</ArticleId><ArticleId IdType="pubmed">30363456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69(6):997&#x2013;1001. doi: 10.1136/gutjnl-2020-321013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321013</ArticleId><ArticleId IdType="pubmed">32241899</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.H., Wang Y.R., Wang Q.H., Chen Y., Chen X., Li Y., et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Molecular Neurodegeneration. 2021;16(1):48. doi: 10.1186/s13024-021-00469-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00469-w</ArticleId><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubomski M., Davis R.L., Sue C.M. Gastrointestinal dysfunction in Parkinson's disease. Journal of Neurology. 2020;267(5):1377&#x2013;1388. doi: 10.1007/s00415-020-09723-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09723-5</ArticleId><ArticleId IdType="pubmed">31989280</ArticleId></ArticleIdList></Reference><Reference><Citation>Luis-Mart&#xed;nez R., Di Marco R., Weis L., Cianci V., Pistonesi F., Baba A., et al. Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown. BMC Neurology. 2021;21(1):332. doi: 10.1186/s12883-021-02364-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02364-9</ArticleId><ArticleId IdType="pmc">PMC8404403</ArticleId><ArticleId IdType="pubmed">34461838</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcantonio E.R. Delirium in Hospitalized Older Adults. The New England Journal of Medicine. 2017;377(15):1456&#x2013;1466. doi: 10.1056/NEJMcp1605501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp1605501</ArticleId><ArticleId IdType="pmc">PMC5706782</ArticleId><ArticleId IdType="pubmed">29020579</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Martin P., Rodriguez-Blazquez C., Kurtis M.M., Chaudhuri K.R. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Movement Disorders. 2011;26(3):399&#x2013;406. doi: 10.1002/mds.23462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23462</ArticleId><ArticleId IdType="pubmed">21264941</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda K., Park C.H., Sunden Y., Kimura T., Ochiai K., Kida H., et al. The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice. Veterinary Pathology. 2004;41(2):101&#x2013;107. doi: 10.1354/vp.41-2-101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1354/vp.41-2-101</ArticleId><ArticleId IdType="pubmed">15017022</ArticleId></ArticleIdList></Reference><Reference><Citation>McRae C., Fazio E., Hartsock G., Kelley L., Urbanski S., Russell D. Predictors of loneliness in caregivers of persons with Parkinson's disease. Parkinsonism &amp; Related Disorders. 2009;15(8):554&#x2013;557. doi: 10.1016/j.parkreldis.2009.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2009.01.007</ArticleId><ArticleId IdType="pmc">PMC2749069</ArticleId><ArticleId IdType="pubmed">19251464</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nature Neuroscience. 2021;24(2):168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Menozzi E., Macnaughtan J., Schapira A.H.V. The gut-brain axis and Parkinson disease: Clinical and pathogenetic relevance. Annals of Medicine. 2021;53(1):611&#x2013;625. doi: 10.1080/07853890.2021.1890330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2021.1890330</ArticleId><ArticleId IdType="pmc">PMC8078923</ArticleId><ArticleId IdType="pubmed">33860738</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;nkem&#xfc;ller K., Fry L., Rickes S. COVID-19, coronavirus, SARS-CoV-2 and the small bowel. Revista Espa&#xf1;ola de Enfermedades Digestivas. 2020;112(5):383&#x2013;388. doi: 10.17235/reed.2020.7137/2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.17235/reed.2020.7137/2020</ArticleId><ArticleId IdType="pubmed">32343593</ArticleId></ArticleIdList></Reference><Reference><Citation>Montanaro E., Artusi C.A., Rosano C., Boschetto C., Imbalzano G., Romagnolo A., et al. Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic. Neurological Sciences. 2022;43(1):341&#x2013;348. doi: 10.1007/s10072-021-05286-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05286-z</ArticleId><ArticleId IdType="pmc">PMC8096160</ArticleId><ArticleId IdType="pubmed">33948763</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F., Ferrario I., Mazziotti D., Berchicci M., Bonazzi M., de Sire A., et al. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for Postacute rehabilitation. Archives of Physical Medicine and Rehabilitation. 2021;102(1):155&#x2013;158. doi: 10.1016/j.apmr.2020.09.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2020.09.376</ArticleId><ArticleId IdType="pmc">PMC7521874</ArticleId><ArticleId IdType="pubmed">32991870</ArticleId></ArticleIdList></Reference><Reference><Citation>Neu D., Kajosch H., Peigneux P., Verbanck P., Linkowski P., Le Bon O. Cognitive impairment in fatigue and sleepiness associated conditions. Psychiatry Research. 2011;189(1):128&#x2013;134. doi: 10.1016/j.psychres.2010.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2010.12.005</ArticleId><ArticleId IdType="pubmed">21196050</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates C.P., Turagam M.K., Musikantow D., Chu E., Shivamurthy P., Lampert J., et al. Syncope and presyncope in patients with COVID-19. Pacing and Clinical Electrophysiology. 2020;43(10):1139&#x2013;1148. doi: 10.1111/pace.14047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.14047</ArticleId><ArticleId IdType="pmc">PMC7461520</ArticleId><ArticleId IdType="pubmed">32840325</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh C.M., Kim H.Y., Na H.K., Cho K.H., Chu M.K. The effect of anxiety and depression on sleep quality of individuals with high risk for insomnia: A population-based study. Frontiers in Neurology. 2019;10:849. doi: 10.3389/fneur.2019.00849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00849</ArticleId><ArticleId IdType="pmc">PMC6700255</ArticleId><ArticleId IdType="pubmed">31456736</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppo V., Serra G., Fenu G., Murgia D., Ricciardi L., Melis M., et al. Parkinson's disease symptoms have a distinct impact on Caregivers' and Patients' stress: A study assessing the consequences of the COVID-19 lockdown. Movement Disorders Clinical Practice. 2020;7(7):865&#x2013;867. doi: 10.1002/mdc3.13030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13030</ArticleId><ArticleId IdType="pmc">PMC7533970</ArticleId><ArticleId IdType="pubmed">33043088</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik S.H., Ahn J.S., Min S., Park K.C., Kim M.H. Impact of psychotic symptoms on clinical outcomes in delirium. PLoS One. 2018;13(7) doi: 10.1371/journal.pone.0200538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0200538</ArticleId><ArticleId IdType="pmc">PMC6044533</ArticleId><ArticleId IdType="pubmed">30005081</ArticleId></ArticleIdList></Reference><Reference><Citation>Palermo G., Tommasini L., Baldacci F., Del Prete E., Siciliano G., Ceravolo R. Impact of coronavirus disease 2019 pandemic on cognition in Parkinson's disease. Movement Disorders. 2020;35(10):1717&#x2013;1718. doi: 10.1002/mds.28254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28254</ArticleId><ArticleId IdType="pmc">PMC7436666</ArticleId><ArticleId IdType="pubmed">32776602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantell M., Rehkopf D., Jutte D., Syme S.L., Balmes J., Adler N. Social isolation: A predictor of mortality comparable to traditional clinical risk factors. American Journal of Public Health. 2013;103(11):2056&#x2013;2062. doi: 10.2105/ajph.2013.301261.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/ajph.2013.301261</ArticleId><ArticleId IdType="pmc">PMC3871270</ArticleId><ArticleId IdType="pubmed">24028260</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra A., Juanes A., Losada C.P., &#xc1;lvarez-Sesmero S., Santana V.D., Mart&#xed; I., et al. Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Research. 2020;291 doi: 10.1016/j.psychres.2020.113254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113254</ArticleId><ArticleId IdType="pmc">PMC7311337</ArticleId><ArticleId IdType="pubmed">32603930</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P.H., Hashmi M.F. StatPearls. StatPearls Publishing; Treasure Island (FL): 2021. Macrolides. (Copyright &#xa9; 2021, StatPearls Publishing LLC)</Citation></Reference><Reference><Citation>Picillo M., Palladino R., Erro R., Alfano R., Colosimo C., Marconi R., et al. The PRIAMO study: Age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson's disease. Journal of Neurology. 2021;268(2):448&#x2013;454. doi: 10.1007/s00415-020-10156-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10156-3</ArticleId><ArticleId IdType="pmc">PMC7880965</ArticleId><ArticleId IdType="pubmed">32809151</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe W., Seppi K., Tanner C.M., Halliday G.M., Brundin P., Volkmann J., et al. Parkinson disease. Nature Reviews. Disease Primers. 2017;3(1):17013. doi: 10.1038/nrdp.2017.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.13</ArticleId><ArticleId IdType="pubmed">28332488</ArticleId></ArticleIdList></Reference><Reference><Citation>Potvin O., Hudon C., Dion M., Grenier S., Pr&#xe9;ville M. Anxiety disorders, depressive episodes and cognitive impairment no dementia in community-dwelling older men and women. International Journal of Geriatric Psychiatry. 2011;26(10):1080&#x2013;1088. doi: 10.1002/gps.2647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.2647</ArticleId><ArticleId IdType="pubmed">21905102</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad S., Holla V.V., Neeraja K., Surisetti B.K., Kamble N., Yadav R., et al. Parkinson's disease and COVID-19: Perceptions and implications in patients and caregivers. Movement Disorders. 2020;35(6):912&#x2013;914. doi: 10.1002/mds.28088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28088</ArticleId><ArticleId IdType="pmc">PMC7264599</ArticleId><ArticleId IdType="pubmed">32304118</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun B.T., Badenes R., Heras La Calle G., Orun O.M., Chen W., Raman R., et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): A multicentre cohort study. The Lancet. Respiratory Medicine. 2021;9(3):239&#x2013;250. doi: 10.1016/S2213-2600(20)30552-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30552-X</ArticleId><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangon C.-M., Krantic S., Moyse E., Foug&#xe8;re B. The vagal autonomic pathway of COVID-19 at the crossroad of Alzheimer's disease and aging: A review of knowledge. Journal of Alzheimer's Disease Reports. 2020;4(1):537&#x2013;551. doi: 10.3233/ADR-200273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/ADR-200273</ArticleId><ArticleId IdType="pmc">PMC7835993</ArticleId><ArticleId IdType="pubmed">33532701</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T.W., Cools R. Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective. Movement Disorders. 2014;29(5):597&#x2013;607. doi: 10.1002/mds.25853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25853</ArticleId><ArticleId IdType="pubmed">24757109</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock P.L., Roiser J.P., Riedel W.J., Blackwell A.D. Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine. 2014;44(10):2029&#x2013;2040. doi: 10.1017/s0033291713002535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291713002535</ArticleId><ArticleId IdType="pubmed">24168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano S., Savva G.M., Bedarf J.R., Charles I.G., Hildebrand F., Narbad A. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. Npj. Parkinson's Disease. 2021;7(1):27. doi: 10.1038/s41531-021-00156-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-021-00156-z</ArticleId><ArticleId IdType="pmc">PMC7946946</ArticleId><ArticleId IdType="pubmed">33692356</ArticleId></ArticleIdList></Reference><Reference><Citation>Rukavina K., Leta V., Sportelli C., Buhidma Y., Duty S., Malcangio M., et al. Pain in Parkinson's disease: New concepts in pathogenesis and treatment. Current Opinion in Neurology. 2019;32(4):579&#x2013;588. doi: 10.1097/wco.0000000000000711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wco.0000000000000711</ArticleId><ArticleId IdType="pubmed">31260418</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari M., Zali A., Ashrafi F., Etemadifar M., Sharma S., Hajizadeh N., et al. Incidence of anxiety in Parkinson's disease during the coronavirus disease (COVID-19) pandemic. Movement Disorders. 2020;35(7):1095&#x2013;1096. doi: 10.1002/mds.28116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28116</ArticleId><ArticleId IdType="pmc">PMC7273007</ArticleId><ArticleId IdType="pubmed">32395849</ArticleId></ArticleIdList></Reference><Reference><Citation>Saldanha D., Menon P., Chaudari B., Bhattacharya L., Guliani S. Acute psychosis: A neuropsychiatric dilemma. Industrial Psychiatry Journal. 2013;22(2):157&#x2013;158. doi: 10.4103/0972-6748.132933.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-6748.132933</ArticleId><ArticleId IdType="pmc">PMC4085811</ArticleId><ArticleId IdType="pubmed">25013320</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Garc&#xed;a D., Oreiro M., P&#xe9;rez P., Fanjul G., Paz Gonz&#xe1;lez J.M., Feal Painceiras M.J., et al. Impact of coronavirus disease 2019 pandemic on Parkinson's disease: A cross-sectional survey of 568 Spanish patients. Movement Disorders. 2020;35(10):1712&#x2013;1716. doi: 10.1002/mds.28261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28261</ArticleId><ArticleId IdType="pmc">PMC7436468</ArticleId><ArticleId IdType="pubmed">32776601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira A.H.V., Chaudhuri K.R., Jenner P. Non-motor features of Parkinson disease. Nature Reviews. Neuroscience. 2017;18(8):509. doi: 10.1038/nrn.2017.91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.91</ArticleId><ArticleId IdType="pubmed">28720825</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirinzi T., Cerroni R., Di Lazzaro G., Liguori C., Scalise S., Bovenzi R., et al. Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy. Neurological Sciences. 2020;41(6):1373&#x2013;1375. doi: 10.1007/s10072-020-04442-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04442-1</ArticleId><ArticleId IdType="pmc">PMC7196180</ArticleId><ArticleId IdType="pubmed">32363506</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalash A., Roushdy T., Essam M., Fathy M., Dawood N.L., Abushady E.M., et al. Mental health, physical activity, and quality of life in Parkinson's disease during COVID-19 pandemic. Movement Disorders. 2020;35(7):1097&#x2013;1099. doi: 10.1002/mds.28134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28134</ArticleId><ArticleId IdType="pmc">PMC7276909</ArticleId><ArticleId IdType="pubmed">32428342</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., Dos Santos Freitas A., et al. Long-COVID and post-COVID health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva F., Brito B.B., Santos M.L.C., Marques H.S., Silva J&#xfa;nior R.T.D., Carvalho L.S., et al. COVID-19 gastrointestinal manifestations: A systematic review. Revista da Sociedade Brasileira de Medicina Tropical. 2020;53 doi: 10.1590/0037-8682-0714-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0714-2020</ArticleId><ArticleId IdType="pmc">PMC7723378</ArticleId><ArticleId IdType="pubmed">33263693</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva A.R., Regueira P., Cardoso A.L., Baldeiras I., Santana I., Cerejeira J. Cognitive trajectories following acute infection in older patients with and without cognitive impairment: An 1-year follow-up study. Frontiers in Psychiatry. 2021;12 doi: 10.3389/fpsyt.2021.754489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.754489</ArticleId><ArticleId IdType="pmc">PMC8716829</ArticleId><ArticleId IdType="pubmed">34975568</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonet C., Tolosa E., Camara A., Valldeoriola F. Emergencies and critical issues in Parkinson's disease. Practical Neurology. 2020;20(1):15. doi: 10.1136/practneurol-2018-002075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2018-002075</ArticleId><ArticleId IdType="pmc">PMC7029239</ArticleId><ArticleId IdType="pubmed">31427383</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C.M., Gilbert E.B., Riordan P.A., Helmke N., von Isenburg M., Kincaid B.R., et al. COVID-19-associated psychosis: A systematic review of case reports. General Hospital Psychiatry. 2021;73:84&#x2013;100. doi: 10.1016/j.genhosppsych.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8546431</ArticleId><ArticleId IdType="pubmed">34717240</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Ahn J.H., Choi I., Mun J.K., Cho J.W., Youn J. The changes of exercise pattern and clinical symptoms in patients with Parkinson's disease in the era of COVID-19 pandemic. Parkinsonism &amp; Related Disorders. 2020;80:148&#x2013;151. doi: 10.1016/j.parkreldis.2020.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7510770</ArticleId><ArticleId IdType="pubmed">33002722</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian I., Farahnik J., Mischley L.K. Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life. NPJ Parkinsons Disease. 2020;6:28. doi: 10.1038/s41531-020-00128-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00128-9</ArticleId><ArticleId IdType="pmc">PMC7545190</ArticleId><ArticleId IdType="pubmed">33083522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D., Antonini A., Leta V., Nordvig A., Smeyne R.J., Goldman J.E., et al. COVID-19 and possible links with Parkinson's disease and parkinsonism: From bench to bedside. NPJ Parkinsons Disease. 2020;6:18. doi: 10.1038/s41531-020-00123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00123-0</ArticleId><ArticleId IdType="pmc">PMC7441399</ArticleId><ArticleId IdType="pubmed">32885037</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K., Numao A., Komagamine T., Haruyama Y., Kawasaki A., Funakoshi K., et al. Impact of the COVID-19 pandemic on the quality of life of patients with Parkinson's disease and their caregivers: A single-center survey in Tochigi prefecture. Journal of Parkinson's Disease. 2021;11(3):1047&#x2013;1056. doi: 10.3233/JPD-212560.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-212560</ArticleId><ArticleId IdType="pubmed">33780375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.H., Mahadeva S., Thalha A.M., Gibson P.R., Kiew C.K., Yeat C.M., et al. Small intestinal bacterial overgrowth in Parkinson's disease. Parkinsonism &amp; Related Disorders. 2014;20(5):535&#x2013;540. doi: 10.1016/j.parkreldis.2014.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2014.02.019</ArticleId><ArticleId IdType="pubmed">24637123</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor D.J., Lichstein K.L., Durrence H.H., Reidel B.W., Bush A.J. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457&#x2013;1464. doi: 10.1093/sleep/28.11.1457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/28.11.1457</ArticleId><ArticleId IdType="pubmed">16335332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticinesi A., Cerundolo N., Parise A., Nouvenne A., Prati B., Guerra A., et al. Delirium in COVID-19: Epidemiology and clinical correlations in a large group of patients admitted to an academic hospital. Aging Clinical and Experimental Research. 2020;32(10):2159&#x2013;2166. doi: 10.1007/s40520-020-01699-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01699-6</ArticleId><ArticleId IdType="pmc">PMC7498987</ArticleId><ArticleId IdType="pubmed">32946031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzun S., Keles A., Okutan D., Yildiran T., Palamar D. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. European Journal of Physical and Rehabilitation Medicine. 2021;57(4):653&#x2013;662. doi: 10.23736/s1973-9087.20.06563-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/s1973-9087.20.06563-6</ArticleId><ArticleId IdType="pubmed">33393277</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide A., Meinders M.J., Bloem B.R., Helmich R.C. The impact of the COVID-19 pandemic on psychological distress, physical activity, and symptom severity in Parkinson's disease. Journal of Parkinson's Disease. 2020;10(4):1355&#x2013;1364. doi: 10.3233/jpd-202251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jpd-202251</ArticleId><ArticleId IdType="pmc">PMC7683090</ArticleId><ArticleId IdType="pubmed">32925108</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wamelen D.J., Wan Y.M., Ray Chaudhuri K., Jenner P. Stress and cortisol in Parkinson's disease. International Review of Neurobiology. 2020;152:131&#x2013;156. doi: 10.1016/bs.irn.2020.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2020.01.005</ArticleId><ArticleId IdType="pubmed">32450994</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W.S., Pollak T.A., Tenorio E.L., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. The Lancet. Psychiatry. 2020;7(10):875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardy E.R., Teodorczuk A., Yarnall A.J. Review of delirium in patients with Parkinson's disease. Journal of Neurology. 2015;262(11):2401&#x2013;2410. doi: 10.1007/s00415-015-7760-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7760-1</ArticleId><ArticleId IdType="pubmed">25957635</ArticleId></ArticleIdList></Reference><Reference><Citation>Villapol S. Gastrointestinal symptoms associated with COVID-19: Impact on the gut microbiome. Translational Research. 2020;226:57&#x2013;69. doi: 10.1016/j.trsl.2020.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.08.004</ArticleId><ArticleId IdType="pmc">PMC7438210</ArticleId><ArticleId IdType="pubmed">32827705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakefield B.J. Risk for acute confusion on hospital admission. Clinical Nursing Research. 2002;11(2):153&#x2013;172. doi: 10.1177/105477380201100205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/105477380201100205</ArticleId><ArticleId IdType="pubmed">11991170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan D., Du T., Hong W., Chen L., Que H., Lu S., et al. Neurological complications and infection mechanism of SARS-COV-2. Signal Transduction and Targeted Therapy. 2021;6(1):406. doi: 10.1038/s41392-021-00818-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00818-7</ArticleId><ArticleId IdType="pmc">PMC8609271</ArticleId><ArticleId IdType="pubmed">34815399</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster R., Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics. 2000;41(6):519&#x2013;522. doi: 10.1176/appi.psy.41.6.519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.41.6.519</ArticleId><ArticleId IdType="pubmed">11110116</ArticleId></ArticleIdList></Reference><Reference><Citation>Weems C.F., Costa N.M., Dehon C., Berman S.L. Paul Tillich's theory of existential anxiety: A preliminary conceptual and empirical examination. Anxiety, Stress, and Coping. 2004;17(4):383&#x2013;399. doi: 10.1080/10615800412331318616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10615800412331318616</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng L.M., Su X., Wang X.Q. Pain symptoms in patients with coronavirus disease (COVID-19): A literature review. Journal of Pain Research. 2021;14:147&#x2013;159. doi: 10.2147/jpr.S269206.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jpr.S269206</ArticleId><ArticleId IdType="pmc">PMC7847371</ArticleId><ArticleId IdType="pubmed">33531833</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitworth S.R., Loftus A.M., Skinner T.C., Gasson N., Barker R.A., Bucks R.S., et al. Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies. Journal of Parkinson's Disease. 2013;3(1):45&#x2013;53. doi: 10.3233/JPD-120149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-120149</ArticleId><ArticleId IdType="pubmed">23938310</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Communications. 2020;2(2):fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Retrieved February 4, 2022, from; 2022. WHO coronavirus (COVID-19) dashboard.https://covid19.who.int/region/searo/country/in</Citation></Reference><Reference><Citation>Xia Y., Kou L., Zhang G., Han C., Hu J., Wan F., et al. Investigation on sleep and mental health of patients with Parkinson's disease during the coronavirus disease 2019 pandemic. Sleep Medicine. 2020;75:428&#x2013;433. doi: 10.1016/j.sleep.2020.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2020.09.011</ArticleId><ArticleId IdType="pmc">PMC7481072</ArticleId><ArticleId IdType="pubmed">32980664</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q., Chen S., Le W. Hyposmia: A possible biomarker of Parkinson's disease. Neuroscience Bulletin. 2014;30(1):134&#x2013;140. doi: 10.1007/s12264-013-1390-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-013-1390-3</ArticleId><ArticleId IdType="pmc">PMC5562575</ArticleId><ArticleId IdType="pubmed">24136244</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Surface M., Chan A.K., Halpern J., Vanegas-Arroyave N., Ford B., et al. COVID-19 manifestations in people with Parkinson's disease: A USA cohort. Journal of Neurology. 2021;1-7 doi: 10.1007/s00415-021-10784-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10784-3</ArticleId><ArticleId IdType="pmc">PMC8418279</ArticleId><ArticleId IdType="pubmed">34482434</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan A., Bryant E.E. StatPearls. StatPearls Publishing; Treasure Island (FL): 2021. Quinolones. (Copyright &#xa9; 2021, StatPearls Publishing LLC)</Citation></Reference><Reference><Citation>Ye Q., Wang B., Zhang T., Xu J., Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2020;319(2):G245&#x2013;G252. doi: 10.1152/ajpgi.00148.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00148.2020</ArticleId><ArticleId IdType="pmc">PMC7414235</ArticleId><ArticleId IdType="pubmed">32639848</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf F., Fahriani M., Mamada S.S., Frediansyah A., Abubakar A., Maghfirah D., et al. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Res. 2021;10:301. doi: 10.12688/f1000research.52216.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52216.1</ArticleId><ArticleId IdType="pmc">PMC8171196</ArticleId><ArticleId IdType="pubmed">34131481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., Wei N., Wang D., Lyu H., et al. The landscape of cognitive function in recovered COVID-19 patients. Journal of Psychiatric Research. 2020;129:98&#x2013;102. doi: 10.1016/j.jpsychires.2020.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipprich H.M., Teschner U., Witte O.W., Schonenberg A., Prell T. Knowledge, attitudes, practices, and burden during the COVID-19 pandemic in people with Parkinson's disease in Germany. Journal of Clinical Medicine. 2020;9(6) doi: 10.3390/jcm9061643.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061643</ArticleId><ArticleId IdType="pmc">PMC7355903</ArticleId><ArticleId IdType="pubmed">32486074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>